Trial Profile
A Phase II Study of Additional Four-week Chemotherapy With Capecitabine During the Resting Periods After Six-week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 28 Aug 2012 New trial record